// App-Quantinova.ai

605 : Response to ado-trastuzumab emtansine according to RANO criteria in central nervous system metastases of HER2 positive breast cancers.

Researchers

Presenter

  • Audrey Mailliez

Principal Investigators

  • Edwina Girard

  • Thomas Boulanger

  • Claire Giraud

  • Jacques Bonneterre

  • Emilie Le Rhun

Medical Centers

  • Centre Oscar Lambret, Lille, France

  • Centre Leonard de Vinci, Dechy, France

  • Lille 2 University, Lille, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • erb-b2 receptor tyrosine kinase 2

  • Human epidermal growth factor receptor 2

Drug/Treatment

  • Trastuzumab emtansine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved